Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Simwel-EZ
Simwel-EZ is a clinically proven lipid-lowering therapy containing Simvastatin and Ezetimibe, designed for effective cholesterol management. By combining a statin with a cholesterol absorption inhibitor, it provides enhanced lipid control for patients at risk of cardiovascular diseases.
Uses of Simwel-EZ
Simwel-EZ is indicated for the treatment of:
Primary Hyperlipidemia (High LDL and total cholesterol levels)
Mixed Dyslipidemia (Elevated LDL, triglycerides, and low HDL)
Familial Hypercholesterolemia (Genetic high cholesterol)
Cardiovascular Risk Reduction (For stroke, heart attack prevention)
Benefits of Simwel-EZ
Dual Mechanism for Effective Cholesterol Reduction
Lowers LDL, Total Cholesterol & Triglycerides
Increases HDL (Good Cholesterol) Levels
Reduces Cardiovascular Event Risks
Clinically Proven Safety & Efficacy
Mechanism of Action of Simwel-EZ
Simvastatin inhibits HMG-CoA reductase, reducing hepatic cholesterol production.
Ezetimibe blocks dietary cholesterol absorption in the small intestine.
This dual approach maximizes lipid-lowering effects, improving cardiovascular health.